DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Pujade-Lauraine E, Fujiwara K, Ledermann JA. et al.
Avelumab alone or in combination with pegylated liposomal doxorubicin versus pegylated liposomal doxorubicin alone in platinum-resistant or refractory epithelial ovarian cancer: Primary and biomarker analysis of the phase III JAVELIN Ovarian 200 trial.
Gynecol Oncol 2019;
154: 21-22
doi:10.1016/j.ygyno.2019.04.053
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.